GLPwatch
Trials (2083)
Page 30 of 35.
- Study of Tirzepatide for Recovery and Alcohol Use Management
- Genetic, Microbiological and Behavioral Factors in Obesity
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- Oral Semaglutide in Patients With Alzheimer's Disease
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
- A Study of LY3537021 in Healthy Participants
- A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
- GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
- Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- GLP1R-imaging in Post-RYGB Hypoglycemia
- Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
- A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- Study on Lixisenatide and Counterregulation to Hypoglycemia
- Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
- GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- Clinical Outcomes of Exenatide Versus Basal Insulin
- Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
- A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
- The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
- 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
- Treating PCOS With Semaglutide vs Active Lifestyle Intervention
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
- Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
- Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Probiotic Intervention on Body Weight
- Young Adults With Early-onset Obesity Treated With Semaglutide
- A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
- A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- Tirzepatide vs Liraglutide in Bone
- Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Safety Evaluation of Adverse Reactions in Diabetes
- SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims